Prevalence of Coronary Endothelial and Microvascular Dysfunction in Women with Symptoms of Ischemia and No Obstructive Coronary Artery Disease Is Confirmed by a New Cohort: The NHLBI-Sponsored Women's Ischemia Syndrome Evaluation–Coronary Vascular Dysfunction (WISE-CVD)
暂无分享,去创建一个
Carl J Pepine | Saibal Kar | Bruce Samuels | C Noel Bairey Merz | Leslee J Shaw | Babak Azarbal | L. Shaw | S. Kelsey | C. Pepine | G. Sopko | E. Handberg | S. Kar | B. Azarbal | B. Samuels | R. Anderson | Janet Wei | George Sopko | Sheryl F Kelsey | B Delia Johnson | R David Anderson | John W Petersen | Puja K Mehta | Eileen M Handberg | Kamlesh Kothawade | Barry Sharaf | J. Petersen | B. Sharaf | P. Mehta | B. D. Johnson | Kamlesh Kothawade | Janet Wei | C. B. Bairey Merz | B. Johnson
[1] T. Meinertz,et al. Endothelial Dysfunction, Oxidative Stress, and Risk of Cardiovascular Events in Patients With Coronary Artery Disease , 2001, Circulation.
[2] Steven E. Nissen,et al. High Prevalence of Coronary Atherosclerosis in Asymptomatic Teenagers and Young Adults: Evidence From Intravascular Ultrasound , 2001, Circulation.
[3] Carl J Pepine,et al. Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study. , 2010, Journal of the American College of Cardiology.
[4] Thomas de Quincey. [C] , 2000, The Works of Thomas De Quincey, Vol. 1: Writings, 1799–1820.
[5] Carl J Pepine,et al. Adverse outcomes among women presenting with signs and symptoms of ischemia and no obstructive coronary artery disease: findings from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) angiographic core laboratory. , 2013, American heart journal.
[6] O. Rimoldi,et al. Effects of Sex on Coronary Microvascular Dysfunction and Cardiac Outcomes , 2014, Circulation.
[7] K. Smith,et al. An intravascular ultrasound analysis in women experiencing chest pain in the absence of obstructive coronary artery disease: a substudy from the National Heart, Lung and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). , 2010, Journal of interventional cardiology.
[8] R Jay Widmer,et al. Prevalence of Coronary Microvascular Dysfunction Among Patients With Chest Pain and Nonobstructive Coronary Artery Disease. , 2015, JACC. Cardiovascular interventions.
[9] P. Alam,et al. R , 1823, The Herodotus Encyclopedia.
[10] D. Kereiakes,et al. Endothelial dysfunction. , 2003, Circulation.
[11] F Van de Werf,et al. Sex, clinical presentation, and outcome in patients with acute coronary syndromes. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes IIb Investigators. , 1999, The New England journal of medicine.
[12] C. Noel Bairey Merz,et al. Women and ischemic heart disease: evolving knowledge. , 2009, Journal of the American College of Cardiology.
[13] P. Alam. ‘E’ , 2021, Composites Engineering: An A–Z Guide.
[14] Pepine,et al. Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: results from the NHLBI WISE study. , 2001, American heart journal.
[15] C. Pepine,et al. Gender differences in the treatment for acute myocardial infarction: bias or biology? , 2007, Circulation.
[16] Miss A.O. Penney. (b) , 1974, The New Yale Book of Quotations.
[17] P. Alam. ‘A’ , 2021, Composites Engineering: An A–Z Guide.
[18] K. Smith,et al. In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: A double-blind randomized study from the National Heart, Lung and Blood Institute Women's Ischemia , 2011, American heart journal.
[19] Galen Cook-Wiens,et al. A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve , 2015, European heart journal.
[20] Piotr J Slomka,et al. Ranolazine improves angina in women with evidence of myocardial ischemia but no obstructive coronary artery disease. , 2011, JACC. Cardiovascular imaging.
[21] N Reichek,et al. The Women's Ischemia Syndrome Evaluation (WISE) study: protocol design, methodology and feasibility report. , 1999, Journal of the American College of Cardiology.
[22] Kevin Barraclough,et al. I and i , 2001, BMJ : British Medical Journal.
[23] P. Alam. ‘L’ , 2021, Composites Engineering: An A–Z Guide.
[24] Carl J Pepine,et al. Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project. , 2009, Archives of internal medicine.
[25] Christopher J. Rush,et al. Stratified Medical Therapy Using Invasive Coronary Function Testing in Angina: The CorMicA Trial. , 2018, Journal of the American College of Cardiology.
[26] R. Califf,et al. Sex differences in mortality following acute coronary syndromes. , 2009, JAMA.
[27] P. Alam. ‘T’ , 2021, Composites Engineering: An A–Z Guide.
[28] R. Sarpong,et al. Bio-inspired synthesis of xishacorenes A, B, and C, and a new congener from fuscol† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c9sc02572c , 2019, Chemical science.
[29] K. Smith,et al. Abnormal Coronary Vasomotion as a Prognostic Indicator of Cardiovascular Events in Women: Results From the National Heart, Lung, and Blood Institute–Sponsored Women’s Ischemia Syndrome Evaluation (WISE) , 2004, Circulation.
[30] Erik Jørgensen,et al. Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. , 2012, European heart journal.
[31] P. Alam. ‘S’ , 2021, Composites Engineering: An A–Z Guide.
[32] J. Hochman,et al. Sex and Race Are Associated With the Absence of Epicardial Coronary Artery Obstructive Disease at Angiography in Patients With Acute Coronary Syndromes , 2010, Clinical cardiology.
[33] S. Reis,et al. Coronary microvascular reactivity is only partially predicted by atherosclerosis risk factors or coronary artery disease in women evaluated for suspected ischemia: results from the NHLBI Women's Ischemia Syndrome Evaluation (WISE) , 2007, Clinical cardiology.
[34] A M Zeiher,et al. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. , 2000, Circulation.
[35] Gebräuchliche Fertigarzneimittel,et al. V , 1893, Therapielexikon Neurologie.
[36] F. Crea,et al. Effects of ivabradine and ranolazine in patients with microvascular angina pectoris. , 2013, The American journal of cardiology.
[37] I. Chetter,et al. Angiotensin converting enzyme inhibitors effect on endothelial dysfunction: a meta-analysis of randomised controlled trials. , 2011, Atherosclerosis.
[38] Danna Zhou,et al. d. , 1840, Microbial pathogenesis.
[39] S. Higano,et al. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. , 2000, Circulation.